Pharmaceuticals
We want to change the way iron deficiency is prevented and treated and have brought to market innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.
Global leader in pharmaceutical quality dextrans
Pharmacosmos is a world-leading manufacturer of dextrans, dextran derivatives and customised dextrans for pharmaceutical use, and the only provider that is approved by both the US FDA and EU authorities. We are also the only supplier of products that comply with each of the major pharmacopeias. We have built a legacy of quality and continue to evolve our portfolio to meet the growing needs of our customers, using innovative and unique fractionation techniques and manufacturing processes without the use of organic solvents, while meeting the strictest CGMP standards.
DEXTRAN
Pharmacosmos offers Pharmaceutical Quality Dextran for a range of different uses, such as active pharmaceutical ingredients (API), or as an excipient for final formulations, drug products, solutions for injection and infusion, in medical devices, and more. We also provide documentation to support the regulatory approval of your product.
PENTAHIBE
We developed PentaHibe®, a natural, carbohydrate-based cryoprotective agent, to provide a safer alternative to DMSO for uncompromising cryopreservation of cells.
PentaHibe® is our dedicated line of cryopreservation formulations designed for cell therapies.
PHARMACOSMOS IS...
A global pioneer in carbohydrate chemistry and a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.
